NEW YORK, NY / ACCESSWIRE / July 23, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Tufin Software Technologies Ltd. (NYSE:TUFN)
If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/tufin-software-technologies-ltd-loss-submission-form?prid=8133&wire=1
Lead Plaintiff Deadline: September 21, 2020
Affected investors purchased TUFN securities pursuant and/or traceable to documents issued in connection with the Company's April 2019 initial public offering and/or its December 2019 secondary public offering
Allegations against TUFN include that: (i) Tufin's customer relationships and growth metrics were overstated, particularly with respect to North America; (ii) Tufin's business was deteriorating, primarily in North America; (iii) as a result, Tufin's representations regarding its sustainable financial prospects were overly optimistic; and (iv) as a result, the documents issued in connection with the Company's initial public offering were materially false and/or misleading and failed to state information required to be stated therein.
Endo International Plc (NASDAQ:ENDP)
If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/endo-international-plc-loss-submission-form?prid=8133&wire=1
Lead Plaintiff Deadline: August 18, 2020
Class Period: August 8, 2017 - June 10, 2020
Allegations against ENDP include that: (i) Endo's and/or its subsidiaries' contributions to the opioid crisis (including, but not limited to, their opioid products' disproportionately negative impact on New York and the fraud that Defendants perpetrated on the New York insurance market) were larger in scope than the Company had represented; (ii) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (iii) the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
United States Oil Fund, LP (NYSE:USO)
If you suffered a loss, contact us at http://www.wongesq.com/pslra-1/united-states-oil-fund-lp-loss-submission-form?prid=8133&wire=1
Lead Plaintiff Deadline: August 18, 2020
The Lawsuit is on behalf of shareholders of United States Oil Fund, LP, who purchased shares between March 19, 2020 and April 28, 2020 and/or pursuant or otherwise traceable to the Fund's March 19, 2020 registration statement.
Allegations against USO include that: (1) unbeknownst to investors, extraordinary market conditions in early 2020 made USO's purported investment objective and strategy unfeasible; (2) as excess oil supply increased and oil prices plummeted, the facilities available for storage in Cushing approached capacity, causing a "super contango" in which the futures prices for oil substantially exceeded the spot price; (3) instead of revealing the known impacts and risks to the Fund, USO held an offering of billions of dollars of USO shares in March 2020; and (4) as a result USO suffered billions of dollars in losses and was forced to abandon its investment strategy.
To learn more, contact Vincent Wong, Esq. either via e-mail email@example.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com: